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The recent cloning of cDNA for murine (1), human (2-4), and rabbit (5) IL-
1 molecules has shown that there are two classes of IL-1 known as IL-la and IL-
1,Q. The cDNAs encode precursor molecules with molecular masses of 33 kD,
whereas the mature, biologically active molecules found in culture supernatants
have molecular masses of 14-18 kD (6-11). NH2-terminal sequence analysis of
human IL-la (9), IL-1,Q (8), and murine IL-la (1) has shown that each mature
molecule is derived from the C001-1-terminal domain of its respective precursor.
Processing of IL-1 precursors appears to occur in conjunction with externaliza-
tion, since only 33-kD precursors are found intracellularly whereas the mature
BAD form is exclusively extracellular (12-14). The precursor NH2-terminal
domains removed during processing are large compared to most lymphokines,
and they lack hydrophobic domains typical of leader or membrane anchor
sequences (1-5). The apparent absence of a leader sequence in addition to the
observed accumulation of human IL-1 (12, 13, 15) and murine IL-I (14, 16)
within activated monocytes and macrophages suggest that the mechanism of IL-
1 secretion is distinct from that of typical secretory proteins, and may represent
a novel pathway of protein secretion. For example, IL-1 clearly differs from the
monokine cachectin (TNF), which has a secretory leader and is efficiently
secreted without any intracellular accumulation (17).
Early attempts to define the subcellular localization of IL-1 molecules have
relied heavily on bioassay of paraformaldehyde-fixed cells. The observation that
activated murine macrophages (18, 19), B lymphocytes (20), and dendritic cells
(21), when fixed, are capable of stimulating murine thymocyte proliferation, has
been interpreted widely as evidence that IL-I is bound to the plasma membrane
of these cells. Unfractionated membranes prepared from murine macrophages
(18) and human monocytes (15) have also been found to stimulate murine
thymocyte proliferation and the activity found in membranes of murine macro-
phages was blocked by anti-IL-1 antiserum (18). Subsequent immunofluorescent
studies of human monocytes with anti-IL-10 antisera (12) failed to confirm the
presence of plasma membrane-bound material and gave staining patterns con-
sistent with the cytosolic localization of the IL-1,8 precursor.
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In the current study, immunoelectron microscopy with specific antibodies to
human IL-1,Q was used to define the subcellular localization of the IL-lei precur-
sor within activated human monocytes, at considerably higher resolution than
obtainable with immunofluorescence microscopy. In particular, the purpose of
this study was to determine whether IL-10, the major species of IL-1 produced
by human monocytes, is present on plasma membranes and whether IL-1,Q gains
entry to the secretory apparatus of the cell. The results indicate that IL-1,d is not
anchored to the plasma membrane but localized in the cytosolic ground sub-
stance . Furthermore, the pathway of IL-10 secretion appears to be distinct from
lysozyme and most hormones in that passage through the Golgi apparatus and
endoplasmic reticulum (ER)' does not occur.
Materials and Methods
Cells. Peripheral blood leukocytes were obtained from healthy human subjects by
leukophoresis, and the mononuclear cell fraction was isolated in a discontinuous Ficoll-
Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) density gradient. Mononuclear cells
were resuspended in RPMI 1640 medium supplemented with 1 % FCS (endotoxin-free;
Gibco Laboratories, Grand Island, NY), 20 mM Hepes, 4 mM glutamine, 100 U/ml
penicillin, and 100 wg/ml streptomycin. For immunoelectron microscopy, the cells were
seeded into 10-cm diameter tissue culture dishes (No. 25020; Corning Glass Works,
Corning, NY) at 108 cells per dish, and the monocytes were allowed to adhere for 1 .5 h
at 37°C in a humidified atmosphere of 5% C02 and air. Most of the contaminating
platelets and lymphocytes were removed using three washes (5 ml each) of Cat+/Mg2+-
free HBSS. These cultures were stimulated with LPS (1 Ag/ml Escherichia coli, strain
055.B5P; Sigma Chemical Co., St. Louis, MO) for either 4 or 20 h, washed three times
with HBSS, and fixed as described below. For immunofluorescence microscopy, mono-
nuclear cells were isolated as detailed above, and plated into 16-mm diameter tissue
culture wells (No. 3524; Costar, Cambridge, MA) containing poly-L-lysine-coated 12-mm
diameter coverglasses at a concentration of 2 x 106 cells per well. After 18-20 h of LPS
stimulation, these preparations were rinsed once with 1 ml of HBSS and fixed as described
below.
Antibodies and Peptides.
￿
Rabbit polyclonal antisera were raised against an internal IL-
1(3 peptide (amino acid residues 197-215) as previously described (13), and shown to be
specific for mature IL-l,d (18 kD) in concentrated monocyte-derived culture supernatants
(13). We purified the IgG fraction of this IL-1,Q antiserum, as well as the preimmune
serum, on a protein A-Sepharose column (Pharmacia Fine Chemicals) using standard
techniques, and used this material in all of our localization experiments. The relevant IL-
I,# peptide (p197-215) and an irrelevant IL-1,B peptide (p117-128) were synthesized and
purified as previously described (13) and used in blocking experiments to assess the levels
of specific staining of our immunoelectron microscopic preparations (see below). Rabbit
anti-human lysozyme IgG that neutralized purified lysozyme in solution, formed a single
precipitation line in double immunodiffusion tests, and specifically stained sections of
human tonsil, was obtained from Accurate Chemical & Scientific Corp. (Westbury, NY).
Affinity-purified goat anti-rabbit IgG (CooperBiomedical, Inc ., Malvern, PA) was conju-
gated to either 5 or 10 nm colloidal gold particles as previously described (22, 23) for our
immunoelectron microscopic experiments. In addition, we obtained a commercial prepa-
ration of 10 nm colloidal gold conjugated to affinity-purified goat anti-rabbit IgG, in
which >80% of the conjugated gold particles were singlets (Janssen Life Sciences Products,
Piscataway, NJ). Just before use, all colloidal gold conjugates were diluted 1/5 with a
solution of 1 % BSA (crystallized, globulin-free; Sigma Chemical Co.) in 100 mM KCI, 20
' Abbreviations used in this paper:
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mM Tris-HCI, pH 8.3, with 0.1% NaN3, and centrifuged at 11,000 g for 30 min at 4°C
to further reduce aggregates. For immunofluorescence microscopy, a FITC-conjugated
affinity-purified goat anti-rabbit IgG was purchased from Boehringer Mannheim Bio-
chemicals (Indianapolis, IN).
Measurement of Intracellular IL-10.
￿
The intracellular accumulation of 33-kD IL-1(3
precursor was detected by immunoblotting. Cultures containing ^-108 human mononu-
clear cells (see above) were stimulated with LPS for 0, 4, or 18 h. After two washes with
ice-cold PBS, the adherent cells were scraped into PBS containing 5 mM N-ethylmaleimide,
2 mM PMSF, and 2 mM EDTA. The mononuclear cells were pelleted, resuspended in
Laemmli sample buffer containing 1 % dithiothreitol, boiled for 5 min, and analyzed by
SDS-PAGE in 15% gels. Immunoblotting analysis was performed as previously described
(13), except that nonspecific binding was blocked with a 5% nonfat dry milk solution (24).
Assay ofSecreted IL-1(3.
￿
Previous immunoblotting experiments have shown that the IL-
I# found in monocyte culture supernatants is the 18-kD mature form (12, 13). This
material binds with high affinity to the human fibroblast IL-1-R (25), whereas the IL-1S
precursor does not bind to this receptor (26). Mature secreted IL-1,B can therefore be
quantitated in a radioreceptor binding assay. While IL-la would also be detected by this
method, the low amounts of IL-la produced by human monocytes relative to IL-10, as
well as the lower affinity of IL-la for the fibroblast IL-1-R (25), suggest that the IL-1-R
binding activity in monocyte supernatants is largely due to IL-1,8. Culture supernatants
were collected after 0, 4, 18, 42, and 66 h of LPS stimulation, centrifuged to remove any
nonadherent cells, and frozen until assay. They were then assayed in a competitive
receptor binding assay as previously described (25); a standard curve was constructed by
assaying known concentrations of human rIL-1,B (1-100 pM) (4).
Immunofuorescence Microscopy.
￿
To assess the effects of various crosslinking fixatives
upon IL-1,B antigenicity, unsectioned monocyte coverslip cultures (see above) were washed
with HBSS and treated with various mixtures of formaldehyde and glutaraldehyde in 0.1
M cacodylate buffer (pH 7.2) and 4.5 mM CaCl2 for 30 min at 23°C. Immunoreactivity
was monitored via immunofluorescence microscopy. Specifically, the fixed cells were
washed, permeabilized with 0.1% Triton X-100 for 4 min at 4°C to permit intracellular
penetration of the antibodies, and incubated in 5 mg/ml NaBH, in 0.1 M Tris HCI buffer
(pH 7.2) for 20 min. The latter treatment was used to reduce free aldehyde groups
introduced by the fixative that would otherwise bind antibodies to the cells nonspecifically.
To lower the background further, the monocytes were also incubated with 5% nonfat dry
milk (24) clarified at 15,000 g for 20 min as previously described (27). After washing in
0.1 M Tris-HCl buffer (pH 7 .8), the monocytes were treated for 1 h with rabbit anti IL-
I# peptide (p197-215) IgG (50-100,ug/ml) in 0.1 M phosphate buffer (pH 7.8), 0.1%
BSA, 0.1% sodium azide, and clarified 0 .1% nonfat dry milk, followed by 1 h in the
fluorescein-conjugated goat anti-rabbit IgG diluted 1/25 in the latter buffer mixture.
Finally, the coverslip cultures were mounted with 5% n-propyl gallate (28) in 0 .1 M
NaHC08 (pH 8 .2), 90% glycerol, and photomicrographs were taken with a Zeiss epifluo-
rescence photomicroscope III as previously described (27).
Ultrathin Cryosectioning and Immunoelectron Microscopy.
￿
LPS-stimulated monocytes in
10-cm diameter culture dishes were fixed as described above, infiltrated in situ with a 7%
acrylamide solution, and separated from their substratum by a rubber policeman. Cell
pellets were then infiltrated with acrylamide containing ammonium persulfate, and
polymerized. Small clumps of embedded cells were dissected out of the hardened acryl-
amide, and cryoprotected by complete infiltration with a solution of 2.3 M sucrose in 0.1
M phosphate buffer (pH 7.2). These specimens were frozen rapidly in liquid nitrogen-
cooled Freon 22. ^-80-nm ultrathin frozen sections were cut at -95°C, and placed on
formvar-coated 200-mesh nickel grids as previously described (29). Reduction of free
aldehydes with NaBH,, adsorption with milk supernatant, and labeling of IL-1fl antigens
with rabbit anti peptide antibodies, were performed directly on the surfaces of the thin
sections as described above. This method ensures unobstructed access of our immuno-
probes to all sectioned subcellular compartments. For controls, the IL-10 p197-215
antibodies were preincubated with excess (100 Ag/ml) relevant (p197-215), or irrelevant392
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FIGURE 1 .
￿
Time course of intracellular and extracellular accumulation of IL-lß in LPS-
stimulated human monocytes . (A) The intracellular accumulation of IL-Iß precursor was
detected by immunoblot analysis of monocyte lysates using anti-IL-10 (p197-215) IgG at 0, 4,
and 18 h of stimulation . (B) Appearance of IL-lß in monocyte culture supernatants (SN) was
measured in a competitive radioreceptor-binding assay that was standardized with known
concentrations of rIL-If . Supernatants were collected at 0, 4, 18, 42, and 66 h of LPS
stimulation .
(p117-128) peptides, clarified at 15,000g, and used in place of untreated IL-10 antibodies
in the staining protocol described above . Additional controls consisted of preimmune
rabbit IgG or rabbit anti-human lysozyme IgG . After extensive washing, thebound rabbit
antibodies were localized using either 5 or 10 nm colloidal gold-conjugated affinity-
purified goat anti-rabbit IgG (see above), and the grids were washed again, fixed with
glutaraldehyde, counter stained, and reembedded as previously described (22, 30) .
To obtain more customary ultrastructural views of LPS-stimulated monocytes, cultures
were prepared as described above, treated with LPS for 20 h, and fixed in situ with a
mixture of 3.5% paraformaldehyde and 2% glutaraldehyde in 0.1 M sucrose, 0.1 M
cacodylate buffer (pH 7.2), and 4.5mM calcium chloride for 16 h at 4 °C . After refixation
in 1% tannic acid, the monocytes were scraped from their substrate, pelleted, and postfixed
with I% osmium tetroxide in 0.1 M cacodylate buffer as previously described (31) . After
embedding in epoxy resin, ultrathin sections were cut and stained with uranyl acetate and
lead citrate (31) . Electron micrographs were taken at 80 kV using a JEOL 100 CX II
electron microscope equipped with a liquid nitrogen-cooled specimen anticontamination
device .
Results
Time Course of IL-10 Accumulation .
￿
To determine when cultures should be
fixed for immunoelectron microscopy, monocytes were stimulated with LPS for
0, 4, 18, 42, or 66 h . Intracellular TL-10 precursor was then assessed by
immunoblot analysis, while extracellular IL-10 accumulation was measured in a
competitive radioreceptor binding assay (see Materials and Methods) . As shown
in Fig . 1A, nearly equivalent amounts of the 33-kD IL-10 precursor were
specifically recognized by our antipeptide (p197-215) IgG in cell lysates after 4
or 18 h of activation ; lower molecular mass IL-10 species were never detected
intracellularly by our antibodies . No IL-10 precursor was observed before LPS
stimulation . As previously reported for activation with LPS and PHA using
immunoblots stained with a different IL-10 antibody recognizing amino acids
117-128 (13), the maximum amount of IL-10 precursor was observed between
18 and 48 h, and its intensity decreased thereafter (data not shown) . Moreover,
IL-1-R binding activity increased substantially in the culture supernatants be-SINGER ET AL .
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FIGURE 2 .
￿
Light micrographs of unsectioned human monocyte cultures that were fixed in
3.5% formaldehyde and permeabilized with 0.1% Triton X-100 at 20 h of LPS stimulation .
(A) Immunofluorescence micrograph obtained with rabbit anti-IL-1~ (p197-215) IgG. The
monocytes are intensely positive for IL-1,8 while lymphocytes (L), and platelets (P) seen in a
corresponding Normarski micrograph (B) are completely unstained .The monocyte cytoplasms
are uniformly stained for IL-1fl, while their nuclei (arrows) and phagocytic vacuoles (arrow-
heads) are unlabeled. Bar, 10 um .
tween 0 and 42 h of stimulation (Fig. 1 B) . Therefore, monocytes stimulated with
LPS for 4 or 20 h were selected for immunoelectron microscopy since active
secretion of IL-1 activity into the culture medium appeared to be in progress at
those times .
Immunofuorescent Staining and Preservation ofIL-1(3 Antigenicity.
￿
We assessed
the preservation of IL-IQ antigenicity as a function of fixation conditions by
observing changes in immunofluorescence staining intensity of fixed and per-
meabilized monocyte cultures at 20 h of LPS activation . Initially, a solution of
3.5% paraformaldehyde was used for periods of 4-30 min. The IL-1,B staining
intensity was found not to diminish with increasing time of fixation with para-
formaldehyde . The IL-1a specific labeling was homogeneously distributed in the
monocyte cytoplasm, while theirouter cell membranes, phagocytic vacuoles, and
nuclei appeared unstained ; contaminating platelets and lymphocytes likewise
were not labeled (Fig. 2) . The anti-IL-10 p197-215 IgG staining intensity seen
with paraformaldehyde was similar to that observed with a periodate-lysine-
paraformaldehyde fixative using anti-IL-1,13 p117-128 (12, 32), but the anti-
p197-215 IgG produced clearer definition of the nuclei and phagocytic vacuoles
(Fig . 2A). When increasing quantities of glutaraldehyde (0.1, 0.3, 0.5, and 1.0%
by volume) were combined with 3.5% paraformaldehyde, a sharp decrease in
IL-10 immunofluorescence occurred at all glutaraldehyde concentrations ex-394
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ceeding 0.1%. A mixture of 3.5% paraformaldehyde and 0.1 % glutaraldehyde
was thus found to preserve optimal levels of IL-1,8 antigenicity; borohydride
reduction and blocking with clarified powdered milk (see Materialsand Methods)
were observed to minimize nonspecific background labeling. As shown below,
this fixative also produced acceptable fine-structural preservation of LPS-acti-
vated monocytes for immunoelectron microscopy.
Immunoelectron Microscopic Localization of IL-10.
￿
To guide our study and
interpretation of the ultrathin frozen sections, we initially characterized the
morphology of LPS-stimulated monocytes using conventional electron micro-
scopic techniques described in Materials and Methods. At 20 h of LPS stimula-
tion, monocytes exhibited a well-developed Golgi apparatus associated with
numerous secretory vesicles (Ve), and an expanded ER consisting of many
anastomosing cisternae (Fig. 3). The secretory Ve diameters ranged from 44 to
96 nm (mean = 59 nm, median = 65 nm, n = 75, SD = 13.76, SE = 1.58). These
cells also contained abundant phagocytic vacuoles and free polysomes in the
cytoplasmic ground substance. In addition, their plasma membranes showed
microvilli (Fig. 6), and many infoldings that penetrated deeply into the cytoplasm
close to the nucleus (Figs. 3 and 5).
Ultrathin frozen sections of monocytes that were glutaraldehyde-fixed at 4 h
of activation exhibited 90.1% of their IL-1,8 antigens localized within the cyto-
plasmic ground substance (Table I). An immunoelectron micrograph of such a
preparation is shown in Fig. 4. Plasma membranes, secretory Ve, ER cisternae,
phagocytic vacuoles, and mitochondria were only sparsely labeled, while the
Golgiapparatus was completely unstainedat the 4-h time point (Fig. 4 and Table
I) . Most of the remaining grains (7.1 %) were associated with the nucleus (Table
I). A similar distribution of IL-10 immunostaining was observed at 20 h of LPS
activation, and micrographs of these preparations are presented in Figs. 5, 6,
and 9. Again, the majority of the anti-IL-1(3 staining (85.8%; Table I) was
confined to the cytoplasmic matrix where it was distributed randomly at loci
distant from the Golgi apparatus (Figs. 5 and 9). Despite active IL-1 secretion
that took place at this time (Fig. 1 B), only occasional grains were associated with
the lumen of the ER (Fig. 6), the Golgi apparatus (Fig. 9), and secretory Ve
(Table 1) . Taken together, these grains never accounted for more than 1-2% of
the total immunolabeling. In the majority of sections, most of the monocyte
surface lacked IL-10 immunostaining, and many transversely sectioned plasma
membranes exhibiting a typical bilaminar structure usually were unlabeled (Figs.
4 and 6). However, sparse quantities (1-2.8%) of IL-10 antigens were detected
in the vicinity (20 nm) of some plasma membranes at both sampling times (Figs.
4 and 5; Table I). Platelets and lymphocytes present in these sections did not
show specific IL-10 labeling.
The anti-IL-1,0 immunogold labeling occurred as singlets (in 62-54% of the
antigenic sites), or as elliptically shaped clusters (in 38-46% of the IL-1 loci)
associated in the plane of the section surface at 4 and 20 h, respectively, of LPS
activation (Figs. 5-7, 9). The lengths of the major cluster axes ranged from 17-
97 nm (mean = 44 nm, median = 50 nm, n = 80, SD = 19.07, SE = 2.13). Many
(49%) of the IL-10antigen clusters were smaller than secretory Ve and Student's
paired t test showed that the mean major axis length of the clusters wasSINGER ET AL .
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FIGURE 3.
￿
Electron micrograph of an epoxy-embedded human monocyte at 20 h of LPS
stimulation, prepared by conventional electron microscopic techniques (see Materials and
Methods) for purposes of morphological orientation . An expanded Golgi apparatus (G) is seen
adjacent to a centriole (C) and the nucleus (N) . Numerous cisternae of ER and Ve are found
throughout the cytoplasm . The surface membrane (arrow) often forms large phagocytic
vacuoles (Va) which penetrate deeply into the cell . Polysomes (arrowhead) and mitochondria
(M) are also conspicuous. Bar, 250 nm .
significantly smaller (p < 0.005) than the mean secretory Ve diameter. These
morphometric data confirm the observation that secretory Ve lacked significant
IL-10 labeling (Table I, Figs . 6 and 9) . Similar staining patterns consisting of
single and clustered immunogold grains were obtained using different sources
of anti-rabbit IgG conjugated to various lots of colloidal gold particles (diameters
of 5-or 10 nm) . To further make certain that the immunogold clusters reflected396
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TABLE I
Quantitative Immunoelectron Microscopic Analysis ofIL-10 Localization in LPS-stimulated
Human Monocytes
Cellular compartments
Numbers represent the total anti-IL-10 IgG-conjugated colloidal gold particles counted in various subcellular compartments visualized in
electron micrographs of immunolabeled ultrathin cryosections of LPS-stimulated human monocytes. The parentheses show the counts per
organelleexpressed as a percentage ofthe total number of gold grains determined for each subgroup ofcells.
' After 4 or 20 h of LPS-stimulation, cultureswere fixed with either 3.5% paraformaldehyde (Form), or 0.1% glutaraldehyde (Glut) plus 3.5%
formaldehyde as described in the Materialsand Methods.
$ Fixed monocytes were ultrathin cryosectioned, and the monocyte sections placed on gridsand stained with rabbit anti-IL-1-,B IgG (specific
for the amino acid sequence 197-215 in mature IL-1-ft), followed by affinity-purified goat anti-rabbit IgG conjugated to l0-nm diameter
colloidal gold particles (Exp.). For controls, monocyte sections were stained with anti-IL-1-,B IgG preincubated with 100 ag/ml purified
peptide (197-215), and the anti-rabbit IgG gold conjugate.
4 Electron micrographswere taken of the monocyte frozen sections immunolabeled with IL-1-0 antibodies, and printed at magnifications ofx
47,000-84,000. One section wassampled per cell, and the variousgroups were blind coded.
I Plasma membrane immunolabeling was defined as the presence of gold grains at or within 20 nm of transversely sectioned orobliquely cut
cell surface membranes.
a true subcellular concentration of IL-10 antigens, and did not represent a
staining artifact, we used the same immunoconjugate and staining protocol in
parallelexperiments to localize fibronectin with rabbit anti-humanplasma fibro-
nectin IgG on ultrathin frozen sections of cultured human fibroblasts. This
system provided an appropriate control since fibronectin antigens are evenly
distributed throughout the extracellular matrix of fibroblasts (22, 29). The
immunogold staining of fibronectin within sectioned matrix cables was very
homogeneousand characteristically nonclustered (datanot shown), thus confirm-
ing the specificity of the clustered labeling patteren for certain IL-l0 antigens
within monocytes.
We performed several controls to ensure that the immunogold staining was
specific for IL-10. Preincubation ofIL-10 (pl97-215) IgG with excess irrelevant
peptide (p117-128) did not alter the pattern or labeling intensity of IL-10
antigens (Fig. 7A), while pretreatment with the relevant peptide (p197-215)
eliminated both singlet and clustered colloidal gold immunostaining (Fig. 7B).
The magnitude of this reduction was from 96 to 98% of the immunogold
labeling obtained with unblocked anti-IL-l0 IgG (Table I). In addition, substi-
tution of preimmune rabbit IgG for anti-IL-1,# IgG in our staining protocol
resulted in similarly low background levels (not shown) .
To control for the capability of our immunoelectron microscopic staining
method to detect proteins synthesized in the ER and concentrated in secretory
Stimula-
tion
time
h
Fixer* Stain*
No. Cells
Sampledl
Cytoplasmic
ground
substance
ER
lumen
Golgi
lumen
Plasma
mem-
branet
Nucleus
Mitochon-
dria
Vesicles
4 Form Exp. 17 2,791 (88.2) 5(0.15) 0 32(l.0) 260 (8.2) 11(0.3) 66(2.0)
4 Form Control 6 79 (69.3) 0 0 0 33 (28.9) 1(0.9) l(0.9)
20 Form Exp. 24 3,273 (88.3) 7 (0.18) 2(0.05) 39(l.0) 238 (6.44) 139 (3.7) 8(0.2)
20 Form Control 15 139 (73.9) 0 0 0 25 (13.2) 24 (12.7) 0
4 Glut + Exp. 14 1,853 (90.1) 0 0 35(l.7) 146 (7.1) 7(0.3) 15(0.7)
Form
4 Glut + Control 5 52 (78.7) 0 0 0 14 (21.2) 0 0
Form
20 Glut + Exp. 10 1,412 (85.8) 12(0.7) 0 47(2.8) 117 (7.1) 52(3.1) 5(0.3)
Form
20 Glut + Control 3 29 (70.7) 0 0 0 10 (24.4) 2(4.8) 0
FormSINGER ET AL .
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FIGURE 4.
￿
This figure and Figs. 5-7 and 9 are immunoelectron micrographs of ultrathin
frozen sections of LPS-stimulated human monocytes indirectly labeled for IL-10 with antipep-
tide (p197-215) IgG, and a goat anti-rabbit IgG 10nm colloidal gold conjugate, as described
in Materials and Methods . All cells depicted were fixed with 3.5% formaldehyde plus 0.1%
glutaraldehyde, except that in Fig . 9 the cells were preserved with 3.5% formaldehyde alone .
G, Golgi apparatus ; ER, endoplasmic reticulum ; M, mitochondrion ; Mv, microvillus; N,
nucleus; P, cell process ; Va, phagocytic vacuole . Bar = 250 nm .
Fig . 4 is a monocyte fixed at 4 hof LPS stimulation, when the intracellular content of IL-
1# is high, but only small quantities of hormone have been secreted (Fig. 1) . IL-I#-specific
labeling is localized in the cytoplasmic ground substance, while ER cisternae, vacuoles (Va),
and the transversely sectioned cell membrane (arrow) are relatively unlabeled . Only sparse
staining is present at the obliquely sectioned plasma membrane in the upper portion of the
micrograph .
granules, ultrathin frozen sections of activated monocytes were stained for
lysozyme with monospecific rabbit antibodies in the protocol used above for IL-
1,Q . Striking concentrations of lysozyme antigens were observed within elongated
cisternae of the ER (Fig . 8A), and in membrane-bound dense secretory granules
^-250 nm in diameter (Fig . 8B) .
Since the use of a glutaraldehyde fixative reduced the level of IL-I#-specific
immunofluorescence observed in LPS-activated monocytes, we also performed
immunoelectron microscopic experiments on stimulated cells preserved with
formaldehyde alone . Although the IL-10 labeling density was increased 43-66%
relative to comparable monocytes fixed with the 0.1% glutaraldehyde solution,
no alterations were observed in the pattern of IL-1,B staining reported above
(Fig . 9, Table I) .398
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FIGURE 5 .
￿
At 20 h after LPS activation, when IL-l# secretion is well underway (Fig . 1), the
Golgi apparatus (G) completely lacks IL-l,Q labeling . IL 1-beta-specific staining is found in the
ground substance of the cytoplasm, where it appears as single gold grains or as elliptical
clusters confined to the plane of the section .The outer cell membrane (arrow) is only sparsely
stained . See first part of legend to Fig . 4 .
Discussion
In the current study we used immunoelectron microscopy to localize IL-1/3
precursor within activated human monocytes . The cells were studied during a
period of active IL-1 secretion as shown by a 40-fold increase in IL-1-R binding
activity in the culture supernatants after LPS stimulation (Fig . 1) . Also, pulse-
chase experiments with ["S]methionine have confirmed that IL-10 is actively
synthesized and secreted at 4 and 20 h of LPS stimulation (Hall, G ., and J.
Schmidt, unpublished observations), i.e ., at the times when our immunoelectron
microscopic observations were made . The highest concentrations of fixatives
consistent wtih optimal antigen retention were used to obtain maximum preser-
vation of subcellular architecture . Furthermore, our interpretation of the frozenSINGER ET AL .
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FIGURE 6. A human monocyte prepared as that shown in Fig . 5, illustrating the lack of
significant IL-1,B staining at the cell surface . The outer cell membrane is unlabeled while IL-
I,# antigens are found randomly distributed throughout the cytoplasmic ground substance .
The lumens of secretoryVe and most cisternae of the ER are not stained, except for the ER
shownby thearrow . See first part of legend to Fig . 4 .
sections was guided by studyofepoxy-embedded sections ofidentically stimulated
cells (Fig. 3) . The specificity of the IL-1a staining pattern was demonstrated by :
(a) immunoblot analysis of cell lysates (Fig . 1A) ; (b) the failure of preimmune
IgG to give staining; (c) nearly complete inhibition of staining by preincubation400
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FIGURE 7 .
￿
Control immunoelectron micrographs demonstrating the specificity of the label-
ing due to anti-IL-10 (p197-215) IgG by preincubation with excess antigen . (A) The typical
cytoplasmic staining pattern outside the ER cisternae is seen despite pretreatment with excess
irrelevant antigen(p117-128). (B) Nearly all labeling is abolished when the anti-IL-1,B peptide
antibodies are preincubated with excess relevant antigen (p197-215) .SINGER ET AL .
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FIGURE 8 .
￿
Ultrathin frozen sections of human monocytes activated with LPS for 20 h and
labeled for lysozyme with a monospecific rabbit antibody using the immunoelectron micro-
scopic staining protocol described for IL-I# (see Materials and Methods) . (A) Bulbous and
elongate cisternae of the ER (arrowheads) exhibit lysozyme-specific staining. (B) Membrane-
enclosed dense secretory granules (arrows) also exhibit high concentrations of lysozyme; a
linear profile ofER is also lysozyme-positive (arrowheads).
of immune IgG with relevant, but not irrelevant, IL-1(3-derived peptides (Fig .
7) ; and (d) demonstration of abundant lysozyme antigens within the ER and
secretory Ve of monocytes labeled with our immunoelectron microscopic pro-
tocol .
The results show that the overwhelming majority of IL-1,8 precursor is local-
ized to the cytosolic ground substance of the cell at both 4 and 20 h of LPS
stimulation . This finding is in agreement with previous light microscopic studies
performed by Bayne et al . (12) using antibodies recognizing a different IL-1,0
antigen . Very few grains were found within the secretory apparatus of the cell,
i.e ., within saccules of the Golgi apparatus, secretory Ve, or cisternae of the ER .
A small but finite amount of specific labeling was associated with the cell nucleus.40 2
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FIGURE 9 .
￿
Illustration ofahuman monocyte fixed solely with 3.5% formaldehyde at 20 h of
activation with LPS . Therandom pattern of IL-1,8 localization within the cytoplasmic ground
substance appears very similar to that observed in sections of monocytes fixed with formalde-
hyde plus glutaraldehyde . Secretory Ve, and cisternae of ER do not contain IL-10 antigens .
The arrowhead depicts only slight IL-1,8 staining in the Golgi apparatus . See first part of
legend to Fig. 4 .
Most of this labeling was observed at the nuclear periphery and is therefore
probably due to superimposition of portions of thejuxtanuclear cytoplasm over
the nuclear border in tangentially oriented sections . While the possibility of
surface-bound IL-1, suggested by previous studies ofmurine cells (18-20), cannot
be entirely eliminated on the basis of our results, <2.8% of all labeled IL-10
antigens were localized to the plasma membrane (Table I) . The latter finding is
in agreement with our inability to (a) demonstrate binding of radiolabeled IL-1/3
to LPS-activated human monocytes, and (b) surface label cell-associated IL-10
using standard lactoperoxidase techniques (Chin, J ., G. Hall, and J. Schmidt,
unpublished observations) . Although paraformaldehyde-fixed human monocytes
do stimulate murine thymocyte proliferation, all of this activity can be accounted
for by IL-1 leaching out of these mildly fixed cells during the course of the
thymocyte assay (Hall, G., andJ . Schmidt, manuscript submitted for publication) .SINGER ET AL.
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Therefore, on the basis of morphological and functional studies, IL-10 appears
to be localized within the cytoplasm, and not on the plasma membrane of
activated human monocytes.
While the IL-1,Q precursor appeared to be mainly localized in the cytosolic
ground substance ofactivated monocytes, the distribution oflabel was not always
homogeneous (Figs. 4-8). The anti-IL-l# immunogold labeling appeared clus-
tered within the cytosol in 38-46% of the antigenic sites observed in 4 and 20 h
specimens. These clusters are probably not an aruiact ofthe labeling technique
in that care was taken to eliminate putative immunogold aggregates before
staining (see Materials and Methods), and 80% of the immunogold conjugate
was composed of singlets. Furthermore, no significant clustering was observed
in parallel immunoelectron microscopic experiments on cultured human fibro-
blasts using the same protocol and goat anti-rabbit IgG gold probe to stain
fibronectin. In those cases where clustering of IL-1,B labeling was observed, all
ofthe gold grains were in a single plane; i.e., they did not appear as heaped-up,
three-dimensional complexes as would be expected for aggregated immunogold
conjugates. Finally, the clustered gold particles, like the singlets, were eliminated
by preincubation of the primary antibodies with relevant peptide. No clusters
were observed with control IgG. We believe that these clusters represent labeling
of several IL-1# precursor molecules concentrated at subcellular loci, and that
they do not result from the use ofpolyclonal antibodies in a sandwich technique
because (a) the IL-10 antigen sequence is short (18 amino acids); (b) the clusters
were planar, and (c) in many cases, the largest dimension was too great to be
accounted for by the aggregation of the immunogold particles at a single
antigenic site.
There are several possible explanations for the observed clustering of anti-IL-
1/0 label. First, the clusters may represent nascent IL-10 precursor molecules on
free polyribosomes. However, the immunoblot analyses performed with this(Fig.
IA) and other (13) anti-IL-1/3 antibodies suggest that lower molecular weight
precursor material is not sufficiently abundant to account for the large number
of clusters observed. Although most secretory vesicles did not contain IL-10
antigens, a second possibility is that the clusters are due to enclosure of IL-10
precursor in secretory Ve that have not been adequately preserved by our
fixation technique. However, the adequate fixation ofmany secretory Ve, as well
as membranes of the Golgi apparatus and ER (Figs. 4-9), argues against this
possibility. Furthermore, the observations that the mean IL-10 antigen cluster
size was smaller than the mean diameter of secretory Ve, and that the clusters
were elliptical in shape whereas the secretory vesicles were round, suggest that
IL-1,Q precursor does not fill these vesicles. A third possibility is that clusters may
form through an interaction ofIL-1,0 precursor with a condensing molecule (33).
Sulfated proteoglycans have been suggested as perhaps serving such a role (34).
Interestingly, complexes composed of class II MHC molecules and chondroitin
sulfate proteoglycan molecules have recently been reported (35, 36). Subcellular
fractionation experiments are being performed to test this hypothesis (37).
The mechanism of IL-10 secretion remains unclear. While the absence of a
typical leader sequence suggested that IL-1 secretion did not involve the Golgi
apparatus, the possibility remained that IL-1,3 beta possesses an atypical, yet404
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functional, leader sequence similar to that found in OVAL (38). The current
study argues that this is unlikely because no substantial labeling of ER, Golgi
apparatus, or secretory Ve was observed. Similarly, while the absence of a
membrane anchor sequence suggested that the IL-10 precursor was not an
integral membrane protein, the possibility remained that IL-1 was bound to
plasma membranes via covalently linked lipid moieties (reviewed in reference
39). Alternatively, a membrane-bound species of IL-10 may have resulted from
a cryptic, alternately spliced mRNA not represented in the cDNAs cloned to
date. Membrane and secreted IgM molecules arise from such a mechanism
(reviewed in reference 40). The current study is important because it argues that
anchorage of human IL-10 to the plasma membranes ofmonocytes by these or
other mechanisms does not occur.
The results ofthis study suggest that the mechanism of IL-10 secretion is likely
to be novel. Since the antibodies used do not recognize human IL-la (9), no
comment can be made on its localization. It has been previously reported,
however, that translation of murine IL-la mRNA in rabbit reticulocyte lysates
in the presence ofdog pancreatic microsomes did not result in processing of the
murine IL-1a precursor (1). This result suggests thatthe aclass ofIL-1 molecules
also lacks a functional leader sequence. Interestingly, acidic fibroblast growth
factor, which is homologous with human IL-1# (41), and basic fibroblast growth
factor, have also recently been found to lack hydrophobic leader sequences (42,
43). It is therefore possible that IL-10 is the prototype ofagroupofinflammatory
and growth mediators using a novel pathway ofprotein secretion.
Summary
The subcellular location of IL-1# was determined using a postsectioning
immunoelectron microscopic method on ultrathin frozen sections of human
monocytes stimulated with LPS. This methodology permits access of antibody
probes to all sectioned intracellular compartments, and their visualization at high
resolution. Staining was performed with a rabbit antibody that specifically
recognized amino acids 197-215 in the 33-kD IL-1# precursor molecule, fol-
lowed by affinity-purified goat anti-rabbit IgG conjugated to 10 nm colloidal
goldparticles. ^-90% ofthe IL-1#antigens were localizedin thegroundsubstance
of the cytoplasm at 4 or 20 h after activation, when both intracellular and
extracellular accumulation of IL-10 was well underway. No significant IL-10
staining was observed on the outer cell membrane, nor within the lumens of the
endoplasmic reticulum (ER), the Golgi apparatus, or secretory vesicles. In con-
trast, lysozyme was localized in the ER and dense secretory granules using these
methods. Our results suggest that IL-1# is not anchored on the plasma mem-
brane, and that its secretion occurs by a novel mechanism that does not use a
secretory leader sequence, nor the classical secretory pathway involving the ER
and Golgi apparatus.
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